Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients

Magnetic Resonance in Medicine

Volumn 43, Issue 6, 2000, Pages 845-853

  Donahue, Kathleen M ^a   Krouwer, Hendrikus G J ^a   Rand, Scott D ^a   Pathak, Arvind P ^a,b   Marszalkowski, Cathy S ^a   Censky, Steven C ^a   Prost, Robert W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Medical College of Wisconsin and Marquette University   (United States)

Author keywords

Brain tumor angiogenesis; Cerebral blood volume; MRI

Indexed keywords

BLOOD; BLOOD VESSELS; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; MORPHOLOGY; TUMORS;

ANTI-ANGIOGENIC THERAPY; BRAIN TUMORS; CEREBRAL BLOOD VOLUME; CONTRAST AGENT; LEAKAGE EFFECTS; MEASUREMENTS OF; TUMOR ANGIOGENESIS; VESSEL DIAMETER;

BRAIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN BLOOD VOLUME; BRAIN TUMOR; CONTRAST ENHANCEMENT; ELECTRON SPIN RESONANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MATHEMATICAL COMPUTING;

EID: 0034045183     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J     Document Type: Article

References (29)

1. Central Brain Tumor Registry for the United States. 1996 Annual Report; 1996.
2. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytomas. J Neurosurg 1998:88:513-520.
3. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-372.
4. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I. Microvessel density in brain tumors. Anticancer Res 1997;17:4747-4754.
5. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR ,Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285.
6. Lindner DJ, Borden EC. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis. Int J Cancer 1997;71: 456-461.
7. Poptani H, Puumalainen AM, Grohn OlH, Loimas S, Kainulainen R, Yla-Horttuala S, Kauppinen RA. Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther 1998;5:101-109.
8. Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Res Imaging 1993;5:14-24.
9. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH, Rosen BR. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51.
10. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y, Kubota T. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-238.
11. Siegal T, Rubinstein R, Tzuk-shina T, Gomori J. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 1997;86:22-27.
12. Fisel CR, Ackerman JL, Buxton RB, Garrido L, Belliveau JW, Rosen BR, Brady TJ. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336-347.
13. Ogawa S, Menon RS, Tank DW, Kim S-G, Merkle H, Ellerman JM, Ugurbil K. Functional brain mapping by oxygenation - dependent contrast magnetic resonance imaging: a comparison of signal characteristics with a biophysical model. Biophys J 1993;64:803-812.
14. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR Contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-566.
15. Weidner N, Folkman J, Possz F, Befelacqua P, Allred EN, Moore DH, Meli S, Giampietro G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
16. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
17. Deane BR, Lantos PL. The vasculature of experimental brain tumours. J Neurolog Sci 1881;49:55-66.
18. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-1111.
19. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Mod 1994;31:601-610.
20. Boxerman J, Bandettini P, Kwong K, Baker J, Davis T, Rosen B, Weisskoff R. The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo. Magn Reson Med 1395;34:4-10.
21. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-799.
22. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. Vessel cooption, regression, and growth in tumor mediated by angiopoietins and VEGF. Science 1999; 234:1994-1998.
23. Weisskoff R, Boxerman J, Sorensen A, Kulke S, Camphell T, Rosen B. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the 2nd Annual Meeting of SMRM, San Francisco, 1994. p 279.
24. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. Berlin, Heidelberg, New York: Springer-Verlag; 1993. p 11-30.
25. Chan JKC, Banks PM, Cleary ML, Delsol G, Wolf-Peeters CD, Falini B, Gatter KC, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Knowles DM, Mason DY. Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Stein H, Warnke RA. A revised European-American classification of lymphoid neoplasms proposed by the international lymphoma study group. Am J Clin Pathol 1995;103:543-560.
26. Bandettini PA, Wong EC, Jesmanowicz A, Hinks RS, Hyde JS, Spinecho and gradient-echo EPI of human brain activation using BOLD contrast: a comparative study at 1.5T. NMR Biomed 1994;7:12-20.
27. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162-173.
28. vanDijke CF, Brasch RC, Roberts TPL, Weidner N, Mathur A, Shames DM, Mann JS, Demsar F, Lang P, Schwickert HC. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198:813-818.
29. Enochs WS, Harsh G, Hochberg F, Weissleder R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999;9:228-232.